product Name:(+/-)-BUTOXAMINE
  • Butoxamine [INN]; (+-)-Butoxamine; (R*,S*)-(+-)-alpha-(1-((1,1-Dimethylethyl)amino)ethyl)-2,5-dimethoxybenzenemethanol; Benzyl alcohol, alpha-(1-(tert-butylamino)ethyl)-2,5-dimethoxy-, DL-erythro-; Butaxamina [INN-Spanish]; Butaxaminum [INN-Latin]; Benzenemethanol, alpha-((1R)-1-((1,1-dimethylethyl)amino)ethyl)-2,5-dimethoxy-, (alphaS)-rel-; Benzenemethanol, alpha-(1-((1,1-dimethylethyl)amino)ethyl)-2,5-dimethoxy-, (R*,S*)-(+-)-; (1R,2S)-2-(tert-butylamino)-1-(2,5-dimethoxyphenyl)propan-1-ol
  • 1937-89-9
  • C15H25NO3
  • 267.3639
  • InChI=1/C15H25NO3/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6/h7-10,14,16-17H,1-6H3/t10-,14-/m0/s1
  • (+/-)-BUTOXAMINE 1937-89-9
  • 1.027g/cm3
  • 391°C at 760 mmHg
  • 1.506
  • 190.3°C
  • 8.18E-07mmHg at 25°C